An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks

Clinical trial NCT00695305 · COMPLETED

Trial details

NCT number: NCT00695305
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Atherosclerosis

Start date: 2008-11-01
Primary completion: 2010-05-01
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.